Cell Therapeutics

Pharma

China's BCI nod, AZ, Astellas—Fierce Pharma Asia

China approved the world's first commercial brain-computer interface. AZ expands cell therapy capabilities in China. Astellas ended a bispecific deal.

Angus Liu Mar 20, 2026 8:00am

J&J, Legend pull ASH paper comparing Carvykti to rival CAR-T

Nov 12, 2025 11:36am

FDA turmoil compounds challenges for cell and gene therapy field

Apr 2, 2025 3:16pm

J&J, Legend to invest $150M in Belgium cell therapy facility

Mar 12, 2025 2:15pm

graphic of a larger shark chomping up a smaller one

BMS buys cell therapy partner 2seventy bio for $286M

Mar 11, 2025 10:12am

BMS angles Breyanzi for another blood cancer

Feb 10, 2025 9:50am